Siegfried Reich, VP, Drug Discovery at SGX PHARMACEUTICALS, INC. (SGXP), sold 781 shares at $1.19 ($929) on 2008-04-15, disclosed to the SEC on 2008-04-16.
Scheduled sale ($929) by VP, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.19 | 300 | $357 | 38.4% |
| 2 | $1.19 | 481 | $572 | 61.6% |
| Total | $1.19 avg | 781 | $929 | 100% |
| Filing → |
| SGXP | SELL | 2008-08-18 | $2K | — | Filing → |
| SGXP | SELL | 2008-07-16 | $2K | — | Filing → |
| SGXP | SELL | 2008-06-17 | $1K | — | Filing → |